Enhancing Non-Viral CAR T Manufacturing 
with MaxCyte Electroporation and
Akadeum Microbubble T Cell Isolation

See how integrating gentle, flotation-based T cell isolation upstream of MaxCyte’s clinically validated electroporation platform improves yield, viability, and transfection efficiency in non-viral engineering workflows.

Watch the recording to explore:

• How upstream T cell isolation impacts performance and consistency in MaxCyte electroporation workflows
• How Akadeum’s microbubble-based isolation compares to magnetic separation for naïve and activated T cells
• Data from DNA and mRNA transient expression workflows, and a representative CRISPR-based CD19 CAR knock-in process
• How pairing microbubble isolation with MaxCyte electroporation improves cell yield, viability, and transfection efficiency in non-viral CAR T workflows
  

Discover the potential of microbubble‑based isolation in closed‑system GMP workflows. 

Hosts:

	Jesse Chen Senior Research Scientist and Applications Specialist Akadeum Life Sciences
	Andrew Guy Mancini Director of Corporate Development MaxCyte